Published in Blood Weekly, August 28th, 2003
In a recent study, scientists in Poland "sought to retrospectively assess risk factors for occurence of and mortality from severe acute graft-versus-host-disease (aGvHD) among 66 patients receiving hematopoietic stem cell transplants (HSCT) from matched sibling donors (MSD)."
"Thirty-six patients were in early and 30 in intermediate or advanced stages of the disease," noted K. Bogunia-Kubik and coauthors at the Polish Academy of Sciences in Wroclaw.
"Twenty-six patients developed severe aGvHD grades II-IV," they wrote in the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.